Listed Funds Trust - Morgan Creek - Exos Active SPAC Arbitrage ETF Overview

Listed Funds Trust - Morgan Creek - Exos Active SPAC Arbitrage ETF Cost of Revenue

Cost of Revenue analysis for CSH.

Quarterly Cost of Revenue

$5.19B

↓ 3.83% YoY

As of Jun 30, 2022

Annual Cost of Revenue (TTM)

$23.32B

↑ 16.97% YoY

Trailing 12 months ending Jun 30, 2022

Average Cost of Revenue (Comparison Companies)

Cost of Revenue History

Cost of Revenue Comparison

Annual Cost of Revenue Growth Rate (%)

Annual Cost of Revenue Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin